We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of SAGE yet.

SAGE Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q1 2026, worth a combined $9 — down 100% from $460K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SAGE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was DekaBank Deutsche Girozentrale, exiting entirely with an estimated $460K sold.

  • 1 institutional investor held Sage Therapeutics (SAGE) as of Q1 2026, down from 2 in Q4 2025.
  • Funds reported $9 of Sage Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Sage Therapeutics positions in Q1 2026 and 1 closed out, a net change of -1 holder.
  • The largest Sage Therapeutics seller in Q1 2026 was DekaBank Deutsche Girozentrale, an estimated $460K sold.

Based on aggregated 13F filings for Q1 2026.